AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Oncolys BioPharma Inc.
  3. Financials
  4. FCF margin (%)

Oncolys BioPharma Inc.【JP:4588】

Market cap
¥67.6B
P/E ratio
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndFCF margin (%) YoY (%)
Dec 31, 2025-6,809.6+5.61%
Dec 31, 2024-6,447.9+202.74%
Dec 31, 2023-2,129.8+1109.85%
Dec 31, 2022-176-35.12%
Dec 31, 2021-271.3-41.93%
Dec 31, 2020-467.2+2422.29%
Dec 31, 2019-18.5-97.37%
Dec 31, 2018-705.6+47.21%
Dec 31, 2017-479.3-7.55%
Dec 31, 2016-518.4-82.18%
Dec 31, 2014-2,908.5

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)